For in vitro diagnostic use. Others Elecsys proBNP II STAT IVD Elecsys® proBNP II STAT CPS_000500 09 315 276 190 9 315 276 190 09315276190 9315276190 09315276190 proBNP G2 STAT Elecsys cobas e 100 V2.1 Elecsys proBNP II STAT 07613336191514 Reagents, kits 100 tests cobas e 601/602 true 09315276500 Elecsys proBNP II STAT en 3 FF0000000630920E FF0000000477010E 09315276190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of N‑terminal pro B‑type natriuretic peptide in human serum and plasma. This assay is indicated as an aid in the diagnosis of individuals suspected of having congestive heart failure and detection of mild forms of cardiac dysfunction.The test also aids in the assessment of heart failure severity in patients diagnosed with congestive heart failure. This assay is further indicated for the risk stratification of patients with acute coronary syndrome and congestive heart failure, and it can also be used for monitoring the treatment in patients with left ventricular dysfunction.The test can help in the cardiovascular risk assessment of patients with type 2 diabetes mellitus. The test is further indicated to aid in the identification of patients at risk with type 2 diabetes mellitus, without known history of cardiovascular disease, to optimize cardioprotective treatment.This test can be used to identify elderly individuals at high-risk for atrial fibrillation.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e 601 and cobas e 602 immunoassay analyzers. en

User profile

Select your user profile

Elecsys^® proBNP II STAT

Overview

Ordering information

Technical documents

Compatible products

Contact us